Potential mechanisms include rapid blood glucose fluctuations, dehydration from reduced appetite, changes in vascular tone, and dose escalation speed
Wider than that, though, is a vexed question that has haunted the corridors of sports global anti-doping apparatus for more than two years now: Should semaglutide the active ingredient in Ozempic, Wegovy, and the broader family of GLP-1 receptor agonist medications be added to the World Anti-Doping Agencys Prohibited List
[27:49] A Did it make you, like, feel weird
[2] [3] Comparing Clinical Trials A randomized trial compared tirzepatide (10 mg or 15 mg) to semaglutide (1.7 mg or 2.4 mg) in adults with obesity but without type 2 diabetes over 72 weeks, showing tirzepatides superior weight loss and waist circumference reduction
F.ChenH.FangF.et al (2021)